Diabetic foot is a kind of limb- and life-threatening complication that is difficult to treat with conventional therapy, especially when accompanied with peripheral arterial insufficiency and severe infection. We present a diabetic patient with a postamputation wound infected by multidrug-resistant Acinetobacter baumannii/haemolyticus, which was resistant to almost all antibiotics. As the clinical response to antimicrobial therapy was poor, antibiotic was discontinued. Autologous platelet-rich gel with anticoagulation, negative pressure wound therapy, and improvement of microcirculation were used successfully to eradicate infection of the superbug and achieve final wound closure.
LaveryLAArmstrongDGWunderlichRPMohlerMJWendelCSLipskyBA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29:1288-1293.
2.
GootzTDMarraA. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther. 2008;6:309-325.
3.
StewartPSCostertonJW. Antibiotic resistance of bacteria in biofims. Lancet. 2001;358:135-138.
4.
DriverVRHanftJFyllingCPBeriouJM, Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52(6):68-70.
5.
CarterMJFyllingCPParnellLK. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty. 2011;11:e38.
6.
SakataJSasakiSHandaK. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program. Ostomy Wound Manage. 2012;58(4):36-49.
7.
ChenLWangCLiuHLiuGRanX. Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro. J Diabetes Res. 2013;2013:269527.
8.
MoojenDJEvertsPASchureRMOverdevestEPvan ZundertAKnapeJT. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008;26:404-410.
9.
YeamanMRTangYQShenAJBayerASSelstedME. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun. 1997;65:1023-1031.
10.
DragoLBortolinMVassenaCRomanòCLTaschieriSDel FabbroM. Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study. PLoS One. 2014;9:e107813.
11.
LiGYYinJMDingHJiaWTZhangCQ. Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model. J Orthop Res. 2013;31:949-956.
12.
KhalafiRSBradfordDWWilsonMG. Topical application of autologous blood products during surgical closure following a coronary artery bypass graft. Eur J Cardiothorac Surg. 2008;34:360-364.
13.
TrowbridgeCCStammersAHWoodsEYenBRKlaymanMGilbertC. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol. 2005;37:381-386.
14.
ArgentaLCMorykwasMJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38:563-576.
15.
FrykbergRMartinETallisATierneyE. A case history of multimodal therapy in healing a complicated diabetic foot wound: negative pressure, dermal replacement and pulsed radio frequency energy therapies. Int Wound J. 2011;8:132-139.
16.
ZhangJHuZCChenDGuoDZhuJYTangB. Effectiveness and safety of negative-pressure wound therapy for diabetic foot ulcers: a meta-analysis. Plast Reconstr Surg. 2014;134:141-151.
17.
KimBSChoiWJBaekMKKimYSLeeJW. Limb salvage in severe diabetic foot infection. Foot Ankle Int. 2011;32:31-37.
